Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial

Steffen Desch*, Jochen Wöhrle, Rainer Hambrecht, Harald Rittger, Ralf Birkemeyer, Bernward Lauer, Petra Neuhaus, Oana Brosteanu, Peter Sick, Matthias Pauschinger, Sebastian Kerber, Klaus Kleinertz, Suzanne De Waha, Ingo Eitel, Gerhard Schuler, Holger Thiele

*Corresponding author for this work
30 Citations (Scopus)
Original languageEnglish
JournalJournal of the American College of Cardiology
Volume62
Issue number13
Pages (from-to)1214-1215
Number of pages2
ISSN0735-1097
DOIs
Publication statusPublished - 24.09.2013

Funding

Please note: The study was sponsored by the University of Leipzig, Heart Center and the University of Leipzig, Clinical Trial Center , which is supported by the Bundesministerium fur Bildung und Forschung . Drs. Desch and Thiele received an unrestricted research grant from Eli Lilly . All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Research Areas and Centers

  • Centers: Cardiological Center Luebeck (UHZL)

DFG Research Classification Scheme

  • 2.22-12 Cardiology, Angiology

Cite this